跳至主要内容
临床试验/PACTR201808204807776
PACTR201808204807776招募中未知

COMPARATIVE EFFICACY OF SULPHADOXINE-PYRIMETHAMINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR INTERMITTENT PREVENTIVE TREATMENT OF MALARIA DURING PREGNANCY: A RANDOMIZED CONTROLLED TRIA

Federal Teaching Hospital Abakaliki0 个研究点目标入组 360 人开始时间: 2018年8月4日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • 1.Pregnant women between 14 weeks and 24 weeks gestation with viable pregnancy.
  • 2.Women who have not received intermittent preventive treatment with sulphadoxine–pyrimethamine during the index pregnancy.
  • 3.Women not allergic to sulphadoxine-pyrimethamine or dihydroartemisinin-piperaquine.
  • 4.Women willing to deliver in the study hospital.

排除标准

  • 1.Women in the first trimester of pregnancy.
  • 2.HIV positive pregnant women
  • 3.Women allergic to sulphadoxine-pyrimethamine or dihydroartemisini-piperaquine.
  • 4.Women with high-risk pregnancies e.g. medical diseases in pregnancy (sickle cell disease, diabetes mellitus, hypertensive disorders in pregnancy) and multiple gestations.
  • 5.Women who do not consent to the study.

研究者

发起方
Federal Teaching Hospital Abakaliki

相似试验